Skip to content
Brand AI

Silverback Therapeutics

Request correction

Corporate brand

UnclaimedRead 2× by AI crawlers

Silverback Therapeutics is a biotech company.

Last updated September 1, 2026

AI crawler reads

2requests

1companies
  • Anthropic2
Profile
2
Controversies
0
JSON · MD
0
First read
Nov 4, 2026
Latest read
Nov 4, 2026

From this site's server log

Overview

Silverback Therapeutics is identified as a biotech company.

Recent events

  • Reported

    Silverback Therapeutics closes $78.5 million Series B financing[2]

    Silverback Therapeutics announced that it had closed an oversubscribed $78.5 million Series B financing round. The proceeds will support development of SBT6050 and advance its ImmunoTAC programs.

Read more

Sources2 sources

  1. 1Silverback Therapeuticswikidata.org
  2. 2Silverback Therapeutics完成7850万美元B轮融资pharmaceutical-business-review.com

Cite this profile: Cite the canonical profile. /brand-wiki/silverback-therapeutics · Editorial policy · How profiles are compiled